Graftless Lateral Maxillary Sinus Lift Balloon by Different Antrostomy Sizes With Simultaneous Implant Placement
Launched by AHMED MOHAMMED KHALIL ALDAHOUK · Aug 14, 2018
Trial Information
Current as of August 02, 2025
Unknown status
Keywords
ClinConnect Summary
control group undergoes for graftless sinus lift using AMBE through large antrostomy with simultaneous implant placement. While, study group undergo for graftless sinus lift using AMBE through small antrostomy with simultaneous implant placement. the aim of the study is assessment the effect of antrostomy size on bone formation in graftless sinus lift with simultaneous implant placement.
CBCT will be done before and after the surgery and after 6 months to assess of amount bone gain in mm.
implant stability after 6 months will be determined by using Osstell. Primary outcome: amount of bone...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients with atrophic maxilla and pneumatization of maxillary sinus with residual bone height from 3-6mm.
- • 2. Both sexes
- • 3. No intraoral soft and hard tissue pathology,
- • 4. No systemic condition that contraindicate implant placement
- Exclusion Criteria:
- • 1. Sinus pathology.
- • 2. Heavy smokers more than 20 cigarettes per day.
- • 3. Patients with systemic disease that may affect normal healing.
- • 4. Psychiatric problems.
- • 5. Disorders to implant are related to history of radiation therapy to head and neck neoplasia or bone augmentation to implant site
About Ahmed Mohammed Khalil Aldahouk
Ahmed Mohammed Khalil Aldahouk is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, he leverages extensive expertise in clinical operations and regulatory compliance to ensure the successful execution of trials. His proactive approach fosters collaboration among multidisciplinary teams, enhancing the integrity and efficiency of the research process. Through a patient-centered philosophy, Aldahouk aims to contribute valuable insights to the medical community and facilitate the development of groundbreaking treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Al Manial, Egypt
Patients applied
Trial Officials
ahmed a dahouk, bsd
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials